Myasterix
Biologicalexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Mar 1, 2016 (NCT02609022)
Timeline
Indications
Studied for
Mechanism of action
- Unspecified targetImmunity, active
immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cv-mg01
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03165435 | Phase 2/Phase 3 (Phase 3) | Jun 23, 2017 | Aepodia, CuraVac, Leiden University, University of Antwerp |
| NCT02609022 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2016 | Aepodia, CuraVac, Leiden University, University of Antwerp |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aepodia | For profit | 2 | 0 | 2 | 2016 |
| CuraVac | For profit | 2 | 2 | 2 | 2016 |
| Leiden University | Academic/Hospital | 2 | 0 | 2 | 2016 |
| University of Antwerp | Academic/Hospital | 2 | 0 | 2 | 2016 |
4 organizations
Page 1 / 1